AI Answer Capsule: Brookhaven R&D Tax Credit Study
What is the Brookhaven R&D Tax Credit Study?
This study provides a comprehensive analysis of the United States federal and Georgia state Research and Development (R&D) tax credit frameworks, specifically focusing on their application within the unique economic and industrial ecosystem of Brookhaven, Georgia. It explores five distinct industry case studies, detailing their economic genesis, technical operations, and the precise legal mechanics required to secure both federal income tax incentives and state-level payroll withholding offsets.
- Key Frameworks Analyzed: IRC Section 41, Section 174/174A, and Georgia O.C.G.A. § 48-7-40.12.
- Industry Clusters Evaluated: Pediatric Healthcare, Big Data & AI, Civil Engineering, Applied Biomechanics, and Cybersecurity.
- Primary Financial Mechanisms: Federal income tax credits, 50% state corporate income tax liability offsets, and direct state payroll withholding relief.
Industry Case Studies and Sector-Specific R&D Analysis
The intersection of Brookhaven’s unique commercial infrastructure and the highly lucrative tax frameworks of the United States and the State of Georgia has cultivated a specialized local economy. The following five case studies analyze specific industries that have anchored themselves in Brookhaven, detailing their economic genesis, technical operations, and the precise legal mechanics of their R&D tax credit eligibility at both the federal and state levels.
Case Study 1: Pediatric Healthcare and Advanced Cellular Therapy Innovation
The medical industry’s formidable presence in Brookhaven is historically anchored by the continuous expansion of the medical district colloquially known as “Pill Hill”. This district began its transformation in the late 1960s when the Scottish Rite facility transitioned from a children’s convalescent home into a comprehensive medical center in 1965. Recognizing the growing regional need for state-of-the-art pediatric care and centralized research facilities, Children’s Healthcare of Atlanta (CHOA) invested heavily in the Brookhaven region, a commitment that culminated in the opening of the Arthur M. Blank Hospital in September 2024. Located at the highly accessible nexus of Interstate 85 and North Druid Hills Road, this monumental 19-story, 2-million-square-foot facility houses 446 licensed beds and serves as the epicenter of a massive pediatric healthcare and research campus. The intense concentration of specialized medical talent, driven significantly by CHOA’s transformative partnership with the Emory University School of Medicine, has positioned Brookhaven as a premier national hub for clinical trials, oncological research, and medical technological advancement.
Within the Arthur M. Blank Hospital complex is the Marcus Center for Pediatric Advanced Cellular Therapy Production Facility, a Good Manufacturing Practice (GMP) laboratory exclusively dedicated to supporting cell and gene therapies for severe childhood diseases, particularly focusing on cancer and blood disorders. Researchers at this facility engage in the continuous development of novel immunotherapies, synthesizing modified T-cells designed to target specific oncological markers in pediatric patients. The synthesis and clinical evaluation of these experimental cellular therapies clearly satisfy the rigorous requirements of the United States federal R&D tax credit. Under the Section 174 Test, the exact dosing, patient efficacy, and potential adverse immunogenic responses of newly formulated gene therapies are inherently uncertain prior to extensive clinical evaluation. The costs incurred in laboratory testing eliminate this uncertainty in the experimental sense. With the passage of the One Big Beautiful Bill Act (OBBBA), the massive domestic laboratory costs and specialized chemical supplies associated with this research are eligible for immediate expensing under Section 174A. Furthermore, the research fundamentally relies on the hard principles of biological sciences and genetics, satisfying the discovering technological information test. The specific cell therapy protocol or biologic agent constitutes the new or improved business component, and researchers engage in a systematic process of experimentation by formulating baseline cellular models, introducing varying viral vectors, and methodically evaluating the targeted destruction of cancer cells through continuous laboratory iteration.
To qualify for the Georgia R&D credit, the physical execution of the research must occur strictly within the state’s borders. Because the Marcus Center for Cellular Therapy operates physically in Brookhaven, the wages of the principal investigators, laboratory technicians, and the cost of highly specialized biological supplies consumed during the experimentation process represent Georgia-sourced Qualified Research Expenses (QREs). In instances where CHOA functions in partnership with private taxable pharmaceutical entities or operates an independent taxable medical research enterprise, these credits become vital financial instruments. For organizations with massive wage expenditures dedicated to specialized medical researchers, the generation of excess state credits is highly probable. These excess credits can be leveraged as a direct offset against the organization’s state payroll withholding tax obligations under Form IT-WH, providing an immediate influx of operating capital that can be reinvested into further pediatric trials. The judicial precedent established in the Georgia Tax Tribunal case George v. Commissioner, which affirmed that the costs to raise living subjects (in that specific case, poultry) as “pilot models” for testing can be fully included as a QRE, provides a robust legal foundation for the inclusion of biological modeling costs within specialized cellular therapy research.
| Therapy Development Phase | Activity Description | Federal Section 41 Qualification | Georgia State Eligibility |
|---|---|---|---|
| Pre-Clinical Modeling | Synthesis of novel viral vectors for T-cell modification. | High – Eliminates specific biological design uncertainties. | Eligible – Performed entirely within the Brookhaven facility. |
| Clinical Trial Execution | Iterative dosing adjustments based on patient biomarker feedback. | High – Process of experimentation relying on biological sciences. | Eligible – Wages of Brookhaven-based clinical researchers qualify. |
| Routine Patient Care | Standard administration of FDA-approved cellular therapies. | Disqualified – Fails the discovery and uncertainty tests. | Disqualified – Not considered experimental research. |
Case Study 2: Big Data, Artificial Intelligence, and Meteorological Information Technology
The Information Technology (IT) sector in Brookhaven was vastly accelerated by the presence of premium corporate real estate within the master-planned Perimeter Center development. In 2017, The Weather Company (then operating as an IBM Business, and later acquired by Francisco Partners in 2024) relocated its global corporate headquarters to the Perimeter Summit complex in Brookhaven. This strategic relocation brought approximately 400 specialized jobs in software development, engineering, technology, and predictive analytics to the city. The availability of robust fiber-optic infrastructure and proximity to the Atlanta metropolitan area’s elite tech talent pipeline made Brookhaven an optimal environment for an enterprise whose daily operations depend on processing over 100 terabytes of third-party data from a network of more than 200,000 individual weather stations worldwide.
The Weather Company focuses intensely on the continuous development of highly sophisticated meteorological algorithms, utilizing Artificial Intelligence (AI) and machine learning to dramatically improve the accuracy of localized forecasting, extreme weather tracking (such as predictive modeling for Winter Storm tracking tools), and automated aviation weather response systems. This requires continuous backend architectural software engineering to ensure data processing latency is minimized while prediction accuracy simultaneously increases. The development of software is historically subject to rigorous Internal Revenue Service (IRS) scrutiny, particularly regarding the “Internal Use Software” exclusion, which mandates that software developed solely for internal general and administrative functions must meet a significantly higher threshold of innovation to qualify for the credit. However, because The Weather Company’s software algorithms are integrated directly into commercial products held for sale, lease, or license to third parties across the aviation, energy, and media sectors, the technology is classified as outward-facing, thereby avoiding the stringent internal-use limitations.
Engineering new AI machine-learning nodes to rapidly process infinitesimal atmospheric pressure variations involves significant technical uncertainty regarding the ultimate algorithmic architecture and the computational efficiency of the server network. The massive domestic engineering labor costs associated with eliminating this uncertainty can be immediately expensed under the new IRC Section 174A provisions for the 2025 tax year and beyond, reversing the restrictive amortization rules of the prior regime. The programming fundamentally relies entirely on the hard science principles of computer science and atmospheric physics. The forecasting application and its underlying predictive algorithms serve as the defined business components. To pass the process of experimentation test, developers at the Brookhaven headquarters must write experimental source code, run parallel simulations against historical weather datasets, and iteratively refine the algorithmic models to achieve superior predictive accuracy without catastrophically overloading the server architecture.
Because the software engineers and data scientists are physically stationed at the 1001 Summit Blvd NE headquarters in Brookhaven, their W-2 taxable wages—which explicitly include performance bonuses and stock option redemptions subject to withholding—qualify comprehensively as Georgia-sourced in-house research expenses. For high-headcount technology firms operating in highly competitive markets, the ability to first offset 50 percent of their Georgia corporate net income tax liability, and subsequently funnel the remaining generated credit into state payroll withholding relief, creates a massive cycle of operational reinvestment. This localized tax advantage is a primary driver for the continued concentration of big data and AI enterprises within the Brookhaven perimeter.
Case Study 3: Civil Engineering and Infrastructure Optimization
The Southeastern United States is currently experiencing unprecedented population influx and municipal infrastructure growth. To address the increasingly complex engineering, environmental, and construction challenges precipitated by this rapid expansion, premier national engineering firms have centralized their operations in strategic logistical hubs. Burns & McDonnell, an industry-leading design and construction firm, opened its first Atlanta office in 1996 and rapidly expanded its presence in Brookhaven, growing its local workforce from three initial team members to over 300 employee-owners. The Brookhaven office focuses heavily on advanced design-build services for critical infrastructure, including municipal water and wastewater treatment, aviation facilities, power generation plants, and complex electrical transmission grids.
While standard civil engineering design does not automatically qualify for R&D tax credits, firms like Burns & McDonnell frequently encounter unique environmental, geological, and structural constraints that require bespoke, experimental engineering solutions. Examples of qualifying activities include the design of custom pumping systems, advanced biological wastewater treatment processes, and complex green infrastructure integrations that must operate under specific regulatory restrictions where no standard template or historical precedent exists. Engineering firms must, however, carefully navigate the restrictive precedents set by recent Tax Court decisions. In the notable case of Phoenix Design Group, Inc. v. Commissioner, a mechanical, electrical, and plumbing engineering firm lost its R&D credit claim because the court determined it failed to demonstrate a systematic process of experimentation, finding instead that the firm merely applied standard, well-known engineering practices to routine client projects.
To differentiate their advanced activities and secure eligibility, engineers in Brookhaven must definitively prove they are eliminating true technical uncertainty, rather than merely applying known skills. For instance, uncertainty must demonstrably exist regarding the appropriate mathematical design of a bespoke water treatment facility capable of handling unprecedented chemical load variables within a restricted geographic footprint. The iterative process must rely strictly on civil, environmental, and mechanical engineering principles. Engineers must contemporaneously document the iterative mathematical modeling of fluid dynamics, the physical stress testing of structural load alternatives, and the CAD-based simulations of piping architecture to achieve the optimal design prior to the commencement of physical construction.
The primary federal and state hurdle for an engineering firm operating in Brookhaven is the strict application of the “funded research” exclusion under Treasury Regulation section 1.41-4A(d). If an engineering firm utilizes standard time-and-materials contracts where the municipal client pays them an hourly rate regardless of the ultimate success or failure of the design, the IRS views the taxpayer as bearing no financial risk, resulting in the complete disallowance of the credit. Furthermore, if the client retains total and exclusive ownership of the final blueprints and underlying intellectual property, the research is deemed funded. To qualify, the firm must operate under fixed-price contracts and strategically structure their contractual language—similar to the successful taxpayer in Smith v. Commissioner—to ensure they retain institutional rights to the underlying intellectual property and methodologies developed during the design phase. If these stringent contractual and technical parameters are met, the wages of the engineering team conducting the CAD modeling and system design within the Brookhaven office constitute highly valuable Georgia QREs, even if the physical infrastructure is eventually constructed in a neighboring jurisdiction.
| Contract Typology | Payment Structure | Intellectual Property Rights | Funded Research Risk Profile |
|---|---|---|---|
| Time & Materials (T&M) | Hourly rate guaranteed regardless of design success. | Client retains exclusive rights to all design work. | High Risk – Disqualified as funded research under Section 41. |
| Firm Fixed Price (FFP) | Set price for deliverable; contractor absorbs cost overruns. | Contractor retains methodology and background IP. | Low Risk – Eligible for R&D credit inclusion. |
| Hybrid / Milestone | Payment contingent upon successful phase completion. | Shared rights; contractor retains institutional knowledge. | Moderate Risk – Requires careful review of termination clauses. |
Case Study 4: Applied Biomechanics and Professional Sports Science
Brookhaven’s strategic geographic location, affluent demographics, and extraordinarily strong institutional ties facilitated a unique joint venture between Emory Healthcare and the Atlanta Hawks professional basketball franchise. The resulting Emory Sports Medicine Complex, located on Hawks Lane in Brookhaven, is a pioneering 90,000-square-foot facility that merges athletic performance with rigorous scientific inquiry. It serves not only as the official training and practice center for the Atlanta Hawks but also houses the East Coast headquarters for the P3 Peak Performance Project (a world-class applied sports science facility) and Emory’s top-tier clinical and physical therapy divisions. This unprecedented convergence of professional athletics and academic medicine has created a premier environment for sports science innovation.
The facility’s operations transcend routine athletic training and standard physical therapy. The complex integrates the use of advanced 3 Tesla MRI scanners, high-speed 3-D motion capture analysis, and comprehensive biochemical blood and sweat testing to develop proprietary, individualized injury prevention algorithms and recovery protocols. Research at the facility involves testing the physiological impacts of various recovery technologies—including cryotherapy chambers and sensory deprivation tanks—on human muscular fatigue, joint stress recovery, and overall athletic performance optimization.
Under the federal Section 174 Test, developing a completely new biomechanical rehabilitation protocol for an anterior cruciate ligament (ACL) tear—involving novel combinations of manual therapy, intramuscular adjustments, and timed cryotherapy exposure—carries inherent uncertainty regarding patient outcome, tissue regeneration, and recovery velocity. The activities fundamentally rely on the hard principles of biological sciences, kinesiology, and physiology. The specific therapeutic protocol, diagnostic technique, or specialized motion-capture analysis algorithm utilized by the clinic serves as the business component. The researchers engage in a strict process of experimentation by systematically altering variables (such as the duration of sensory deprivation, or the specific angle of 3D motion stress) and meticulously tracking the biochemical and biomechanical outcomes of the athletes, continuously evaluating these alternatives to optimize recovery.
The physical operations of the Emory Sports Medicine Complex and the P3 Peak Performance Project in Brookhaven require the employment of highly compensated orthopedic surgeons, sports cardiologists, and biomechanical researchers. The portion of their W-2 wages that is directly dedicated to qualified experimental research activities (such as designing new motion-capture evaluation models, as distinctly opposed to providing routine patient care or standard physical therapy) qualifies for the 10 percent Georgia state credit. However, specific supply exclusions under federal law must be carefully navigated: under Section 41(b)(2)(C), costs for depreciable property, such as the multi-million dollar 3 Tesla MRI machine or permanent hydrotherapy pools, cannot be claimed as a supply QRE. Conversely, tangible, non-depreciable laboratory supplies—such as single-use biochemical assay kits for sweat analysis or experimental kinetic tape consumed during the research process within the Brookhaven facility—are fully eligible as both federal and Georgia supply QREs.
Case Study 5: Cybersecurity and Payment Compliance Software Engineering
The broader Metro Atlanta area is frequently referred to within the financial industry as “Transaction Alley,” processing an estimated 70 percent of all credit card transactions in the United States. Recognizing the absolute necessity of proximity to this massive financial infrastructure and the deep pool of associated technical talent, global cybersecurity and compliance corporations have established major operational footprints within the region. VikingCloud, a prominent industry leader in cybersecurity and Payment Card Industry (PCI) compliance that processes billions of transactions globally, leverages the Brookhaven technology corridor to engineer advanced security solutions explicitly targeting Small and Medium-Sized Businesses (SMBs).
The cybersecurity threat landscape evolves on a daily basis, requiring firms to constantly innovate or face immediate obsolescence. Recent research highlights that cyberattacks have escalated rapidly in both frequency and severity, a surge largely driven by the deployment of adversarial Artificial Intelligence by malicious actors. VikingCloud’s R&D operations focus relentlessly on developing proprietary, AI-driven threat detection software, highly automated compliance auditing tools, and real-time network vulnerability scanners designed to operate without disrupting the daily operations of their SMB clients.
Defeating novel AI-driven malware requires the continuous design of detection algorithms where the technical capability and optimum code structure are completely uncertain at the project’s inception, satisfying the core Section 174 requirements. This intense R&D relies entirely on the principles of computer science, targeting the commercial cybersecurity software suite or the backend network infrastructure architecture as the relevant business component. Brookhaven-based engineers engage in systematic threat-simulation, advanced penetration testing, and iterative coding to evaluate exactly how differing algorithmic structures can isolate and neutralize network intrusions without causing false-positive downtime for the end-user. When applying the federal “Shrink-Back Rule,” if a massive new cybersecurity software suite fails the four-part test as a singular entity, the engineers can shrink the analysis down to a specific, highly experimental encryption module within the suite, allowing that specific subcomponent to qualify for the credit.
Cybersecurity R&D is an intensely labor-driven endeavor. For a company employing elite software engineers and threat analysts in Brookhaven, the payroll base is remarkably high. By executing the Georgia R&D tax credit framework, the company can first offset 50 percent of its state corporate income tax liability. Because software companies often operate with tight margins during growth phases or mandate high reinvestment ratios, they frequently generate excess R&D credits that far exceed their income tax liability. The ability to elect the payroll withholding offset via Form IT-WH is arguably the most powerful economic lever in the Georgia tax code for this specific industry. By directly reducing the cash outgoing for employee state tax withholding, the firm immediately increases its operating liquidity, allowing it to aggressively hire additional cybersecurity talent and further expand its physical footprint within Brookhaven.
The Historical and Economic Genesis of Brookhaven
To fully comprehend why these highly specific, technology-driven industries have clustered in Brookhaven, Georgia, it is imperative to examine the historical and geographic evolution of the region. Located in the northern perimeter of the Atlanta metropolitan area, Brookhaven’s modern economic identity is inextricably linked to the master-planned development of the Perimeter Center and the adjacent, rapidly expanding medical district.
The foundation of this corporate nexus was established in 1970 when the real estate development firm Taylor & Mathis, in a strategic financial partnership with MetLife, initiated the development of Perimeter Center on a massive 510-acre land assemblage. Over the subsequent decades, this area evolved systematically into one of the largest and most successful corporate office and mixed-use environments in the United States, ultimately encompassing over 3.2 million square feet of premium office space, luxury hotels, and high-end retail centers. Concurrently, the medical sector in the region began to expand at an exponential rate. Following the structural expansion of the Scottish Rite children’s convalescent home into a full-fledged, comprehensive medical center in 1965, and the subsequent arrival of Northside Hospital in 1970, the area experienced a boom in healthcare infrastructure.
The region’s connectivity was further enhanced by a long-fought southward extension of Georgia 400 in 1993, which provided a direct, high-speed highway link to the financial center of Buckhead. This was followed by the critical integration of the Metropolitan Atlanta Rapid Transit Authority (MARTA) rail system, with the Dunwoody and Medical Center stations opening in 1996, securely linking the Perimeter workforce to the broader metropolitan area.
As the Perimeter Center grew into an economic powerhouse, municipal borders began to shift. Perimeter was a focal point for the incorporation of Sandy Springs in 2005 and Dunwoody in 2008. Brookhaven officially incorporated as a city shortly thereafter in 2012, successfully capturing the remaining high-value commercial real estate southward from the Dunwoody city limit at Interstate 285. The incorporation was economically contentious; DeKalb County threatened litigation over the inclusion of the Perimeter district and its massive tax base into the new city of Dunwoody, though the lawsuit never materialized.
Today, the City of Brookhaven boasts a highly educated, diverse workforce and an economy that employs over 33,300 individuals. The occupational demographics are heavily skewed toward advanced technical, medical, and professional fields. In 2023, the largest industrial sectors operating within Brookhaven included Professional, Scientific, and Technical Services (employing 7,301 individuals), Health Care and Social Assistance (3,309 individuals), and Finance and Insurance (3,004 individuals). The highest paying industries in the region further reflect this shift toward specialized knowledge economies, with Information Technology sectors boasting average salaries exceeding $120,000. The city’s economic development strategy actively promotes its strategic location, state-level tax incentives, and high quality of life to aggressively attract corporate headquarters and specialized research facilities. This meticulously cultivated environment directly facilitates the high-level research activities rewarded by the federal and state tax codes.
United States Federal R&D Tax Credit Jurisprudence and Mechanics
The federal R&D tax credit, permanently codified under Section 41 of the Internal Revenue Code (IRC), serves as the primary domestic economic incentive for corporations to invest in technological advancement, engineering, and scientific innovation within the United States. The statutory language governing Section 41 is notoriously complex, characterized by dense, super-technical statutory definitions (often nested within other definitions), mathematical formulas, and rigorous contemporaneous documentation requirements. The United States Tax Court has routinely commented that the research credit is one of the most complicated provisions in the entire Code, representing a highly scrutinized area of corporate tax law. To successfully qualify for the credit, a taxpayer must satisfy a stringent legal framework universally known as the Four-Part Test, while simultaneously navigating various statutory exclusions.
The Four-Part Test for Qualified Research
Under IRC Section 41(d), an activity must demonstrably meet all four of the following criteria to be legally classified as “qualified research”. These tests are not applied generally to the company as a whole; rather, they must be applied separately and distinctly to each business component developed by the taxpayer.
The foundational requirement is the Section 174 Test. This test dictates that the expenditures claimed must be legally eligible for treatment as expenses under IRC Section 174, meaning they must be incurred in connection with the taxpayer’s active trade or business and must represent research and development costs in the experimental or laboratory sense. The core legal concept of this test focuses entirely on the elimination of uncertainty. Technical uncertainty exists if the information available to the taxpayer at the exact onset of the project does not establish the capability or method for developing or improving the product, or the appropriate final design of the product. The Internal Revenue Service (IRS) Audit Techniques Guide specifically clarifies that qualification depends entirely on the nature of the research activity itself, rather than the ultimate commercial success, the nature of the product, or the level of technological advancement achieved by the final product. Consequently, routine quality control testing, efficiency surveys, management studies, consumer surveys, advertising, and the acquisition of another entity’s patent are explicitly excluded from Section 174 treatment.
The second requirement is the Discovering Technological Information Test. The research activities must be undertaken specifically for the purpose of discovering information that is technological in nature. The process of experimentation utilized by the taxpayer must fundamentally rely on the established principles of the hard sciences: the physical sciences, biological sciences, engineering, or computer science. The Treasury Regulations offer a critical safe harbor here, clarifying that there is no requirement to obtain knowledge that exceeds, expands, or advances the common knowledge of skilled professionals in a particular field; the discovery only needs to be new to the taxpayer conducting the research.
The third requirement is the Business Component Test. The application of the discovered technological information must be intended for use in the development of a new or improved “business component” of the taxpayer. The statute defines a business component very broadly to include any product, process, computer software, technique, formula, or invention that is held for sale, lease, license, or used internally within the taxpayer’s own trade or business. The taxpayer must maintain sufficient internal documentation to establish a direct, undeniable nexus between the specific research activities claimed and the relevant business component produced.
The final requirement is the Process of Experimentation Test. The law dictates that substantially all—which the IRS defines strictly as 80 percent or more—of the research activities must constitute elements of a process of experimentation for a qualified purpose. This requires a methodological, scientific approach designed to evaluate one or more alternatives to achieve a result where the capability, method, or appropriate design is uncertain at the start of the project. To legally pass this test, the taxpayer must systematically identify the core uncertainty, formulate hypotheses or technical alternatives to eliminate that uncertainty, and conduct a process (such as CAD modeling, physical simulation, or systematic trial and error) to evaluate those alternatives. Furthermore, the experimentation must relate to a qualified purpose—specifically, a new or improved function, performance, reliability, or quality. Research relating merely to style, taste, cosmetic upgrades, or seasonal design factors explicitly fails the qualified purpose requirement.
The “Shrink-Back” Rule
If a massive, multi-year engineering or software project fails to meet the Four-Part Test at the macro-level of the entire product or process, the taxpayer is permitted to utilize the administrative “Shrink-Back Rule”. This principle dictates that the four tests are applied sequentially to smaller and smaller subcomponents of the overall business component until a specific subset of elements is identified that satisfies all requirements, or until the most basic element is reached and ultimately fails.
Statutory Exclusions and the “Funded Research” Doctrine
Even if a project satisfies the rigorous Four-Part Test, it may still be completely disqualified under several statutory exclusions outlined in IRC Section 41(d)(4). Excluded activities include research conducted after the onset of commercial production, the adaptation or duplication of existing business components (reverse engineering), social sciences research, and research conducted outside the United States or its territories.
One of the most complex and heavily litigated exclusions is the prohibition against “funded research” under Treasury Regulation section 1.41-4A(d). According to section 41(d)(4)(H), qualified research does not include research to the extent it is funded by a contract, grant, or otherwise by another person or governmental entity. For contractors in Brookhaven performing R&D for third-party clients, eligibility hinges entirely on a two-pronged legal analysis:
First, examiners must evaluate the financial risk. Payment for the research activities must be strictly contingent upon the success of the research. If the taxpayer operates under a time-and-materials contract where they are paid a guaranteed hourly rate regardless of the project’s success or failure, the IRS generally views the research as funded by the client. Second, the taxpayer must retain substantial rights in the results of the research. If the client retains exclusive ownership of the intellectual property, designs, or formulas, and the taxpayer must legally pay to utilize the research results in the future, the taxpayer lacks substantial rights, rendering the research funded.
The Legislative Evolution of Section 174 and 174A
The legislative landscape surrounding the deductibility of R&D expenses has undergone extreme volatility over the past decade, heavily impacting corporate tax strategies. Historically, taxpayers were allowed to immediately deduct domestic R&E expenses in the exact tax year they were incurred, providing massive cash-flow benefits to innovative firms. However, the Tax Cuts and Jobs Act (TCJA) of 2017 fundamentally altered this dynamic. The TCJA mandated that for tax years beginning after December 31, 2021, specified research or experimental (SRE) expenditures had to be capitalized and amortized over a period of five years for domestic research and fifteen years for foreign research.
This capitalization mandate severely impacted corporate cash flows and stifled innovation budgets until the passage of the One Big Beautiful Bill Act (OBBBA) in July 2025. The OBBBA created new IRC Section 174A, which reinstated permanent, immediate expensing for domestic R&E expenditures paid or incurred in taxable years beginning after December 31, 2024. Crucially, foreign R&E expenditures remain strictly subject to the fifteen-year amortization requirement under the amended Section 174, creating a massive geographic tax advantage for domestic operations centralized in hubs like Brookhaven.
To manage the transition between these two diametrically opposed tax regimes, the IRS issued Revenue Procedure 2025-28, providing specific transition rules for taxpayers. The legislation includes a retroactive provision that allows businesses to elect to accelerate their previously unamortized domestic R&E costs from tax years 2022 through 2024 into the first tax year beginning after December 31, 2024. Taxpayers are also granted the option to spread these massive deductions evenly over the 2025 and 2026 tax years to prevent overwhelming their current year tax liability. Small businesses—defined under the Section 448(c) threshold as having average annual gross receipts under $31 million for the prior three tax years—were granted even greater flexibility, allowing them to elect retroactive expensing for 2022-2024 by amending all affected prior returns.
| Tax Policy Era | Domestic R&E Treatment | Foreign R&E Treatment | Primary Corporate Impact |
|---|---|---|---|
| Pre-2022 (Historical) | Immediate Expensing | Immediate Expensing | High liquidity; global R&D encouraged. |
| 2022 – 2024 (TCJA) | 5-Year Amortization | 15-Year Amortization | Severe cash-flow restriction; increased taxable income. |
| Post-2024 (OBBBA Sec 174A) | Immediate Expensing | 15-Year Amortization | Resurgence of domestic R&D; foreign R&D penalized. |
The Georgia State Research and Development Tax Credit Framework
The State of Georgia supplements the federal incentives with a robust, independently calculated R&D tax credit designed specifically to encourage the retention and rapid expansion of specialized technological industries within state borders. Codified at O.C.G.A. § 48-7-40.12, the Georgia R&D tax credit provides a 10 percent credit on the incremental increase in qualified research expenses conducted physically within Georgia.
Statutory Eligibility and Base Amount Mechanics
To legally claim the Georgia credit, a business enterprise must first successfully claim and be allowed the federal research credit under IRC Section 41 for the exact same taxable year. The statutory definition of a “business enterprise” is restricted to entities engaged in manufacturing, warehousing and distribution, processing, telecommunications, broadcasting, tourism, and research and development industries; retail businesses are explicitly excluded from participation. Furthermore, all wages paid and all purchases of services and supplies claimed must be strictly sourced to research conducted physically within the State of Georgia.
The credit amount is determined by calculating 10 percent of the excess of the current year’s Georgia Qualified Research Expenses (QREs) over a mathematically defined “base amount”. The Georgia base amount calculation requires the taxpayer to determine the product of their current taxable year’s Georgia-apportioned gross receipts and the lesser of two specific figures: a statutory fixed ratio of 0.300 (30 percent); or the average ratio of the company’s aggregate QREs to its Georgia gross receipts for the preceding three taxable years. If a business enterprise had no Georgia gross receipts during any one or more of the three preceding tax years (a scenario common for newly relocated startups or out-of-state expansions into Brookhaven), the base amount strictly defaults to the product of the current year Georgia gross receipts and 0.300.
Credit Utilization: Income Tax Offsets and Payroll Withholding
The utilization mechanics of the Georgia R&D credit are highly favorable. The generated credit may be utilized to offset up to 50 percent of the business’s remaining Georgia net income tax liability in a given year, after all other state credits (such as the Job Tax Credit or Investment Tax Credit) have been fully applied. Any unused credit generated in tax years beginning prior to January 1, 2025, may be carried forward for a period of ten years, while credits generated on or after January 1, 2025, carry a shortened five-year carryforward provision.
The most powerful economic mechanism within the Georgia code allows taxpayers to monetize excess R&D credits by applying them directly against the state payroll withholding tax liabilities of their employees. To execute this maneuver, the business must first successfully file Form IT-RD, along with Federal Form 6765 attached to their state income tax return for the year the QREs were incurred. Following this, the taxpayer must electronically file Form IT-WH (Notice of Intent) through the Georgia Tax Center. Recent statutory upgrades extended the deadline for making or amending this payroll withholding election up to three years after the original return due date (including extensions), providing significant retroactive planning opportunities for corporate tax departments. The Georgia Department of Revenue subsequently issues a Letter of Eligibility dictating the exact amount applicable against withholding. Once made, the election is irrevocable for that tax year and can only offset future withholding—meaning no refunds are issued for past withholding payments already remitted to the state.
| Credit Attribute | Federal R&D Credit (IRC Section 41) | Georgia State R&D Credit (O.C.G.A. § 48-7-40.12) |
|---|---|---|
| Geographic Requirement | United States and its territories. | Strictly within the State of Georgia. |
| Payroll Withholding Offset | Limited to Qualified Small Businesses (QSBs) under $5M gross receipts. | Available to all qualifying business enterprises; no gross receipts cap. |
| Base Amount Calculation | Complex historical fixed-base percentage. | Lesser of 30% or prior 3-year average QRE-to-receipts ratio. |
| Income Tax Offset Limit | General Business Credit limitations apply. | Capped at 50% of remaining GA net income tax liability. |
Audit Defense, Case Law Precedents, and Substantiation
The successful application of these tax frameworks requires rigorous, uncompromising adherence to the substantiation requirements detailed in the IRS Audit Techniques Guide and state regulations. The overarching trend in federal R&D tax litigation from 2019 through 2024 indicates an increasingly hostile environment for taxpayers lacking pristine documentation. A review of recent federal R&D opinions highlights a government win record of 13 to 1 in the Tax Court and Circuit Courts, emphasizing the immense difficulty of prevailing in an audit without exceptional record-keeping.
The Tax Court explicitly rejected estimated time allocations and post-hoc rationalizations in the recent CPI case. In that ruling, the court found that CPI failed to meet the technical uncertainty and process of experimentation requirements, noting that conflicting estimated time allocations produced years after the fact were entirely insufficient to prove that a systematic process of experimentation actually occurred. Furthermore, for five of CPI’s nineteen projects, the court found they did not retain substantial rights to the research results, triggering the funded research exclusion. Consequently, Brookhaven enterprises must implement rigorous internal controls, including project-based time-tracking systems linking specific employee hours directly to qualified business components, technical design records, schematic CAD iteration logs, and failed testing protocols.
Under the IRS “Substantially All” rule, if an employee spends 80 percent or more of their time on qualified services, their entire wage may be claimed as a QRE; if they spend less than 80 percent, only the exact percentage of time documented is permitted. Crucially, the IRS specific guidelines exclude “direct supervision” by higher-level management to whom first-line managers report, even if those executives possess advanced scientific backgrounds. General administrative support, such as human resources personnel, payroll accountants, or janitorial staff, is strictly disallowed from wage QRE calculations.
When calculating the incremental increase in R&D spending, the IRS aggressively enforces the IRC Section 41(c)(5)(A) consistency requirement. The QREs and gross receipts used to compute the fixed base percentage in historical years must be determined on a basis completely consistent with the laws and methodologies applied in the current credit year. If a Brookhaven software firm begins claiming a new type of technological expense as a QRE in 2025 that it did not claim in its historical base period, it must retroactively adjust its base period calculation to include similar historical expenses, thereby preventing an artificial inflation of the incremental credit. As demonstrated in Research, Inc. v. United States, taxpayers must be prepared to prove their base year expenses through actual historical records; if documentation is destroyed, the credit will be disallowed, as extrapolation is forbidden.
Conversely, taxpayers have achieved specific victories when their contracts and documentation are immaculate. In Smith et. al. v. Commissioner, the Tax Court ruled in favor of an architectural design firm (AS+GG), denying the IRS’s motion for summary judgment regarding funded research. The taxpayers successfully argued that the IRS failed to identify a contractual clause that explicitly divested the firm of all substantial rights, and proved that milestone-based payments implicitly carried financial risk, as payment was contingent upon successful design completion.
At the state level, the Georgia Department of Revenue mirrors federal scrutiny. Taxpayers must maintain extensive workpapers linking the granular data on Form IT-RD directly to their Federal Form 6765. Because the Georgia base amount strictly utilizes Georgia-sourced gross receipts (determined via the state apportionment factor) and Georgia-sourced QREs, companies with multi-state operations must maintain robust geographic accounting firewalls to prevent federal spillover. The failure to electronically file the Notice of Intent (Form IT-WH) within the statutory window will result in the total, irrevocable disallowance of the highly lucrative withholding tax benefit, representing a severe operational failure for any corporate tax team. The judicial precedents set by both the United States Tax Court and the Georgia Tax Tribunal mandate that Brookhaven enterprises view the R&D tax credit not merely as an accounting exercise, but as a rigorous legal compliance protocol requiring deep integration between engineering, legal, and financial departments.
The information in this study is current as of the date of publication, and is provided for information purposes only. Although we do our absolute best in our attempts to avoid errors, we cannot guarantee that errors are not present in this study. Please contact a Swanson Reed member of staff, or seek independent legal advice to further understand how this information applies to your circumstances.










